Search Results
Results found for "Gregory Tall"
- How to Design GPCR Drugs That Work in Vivo: Strategy, Tools, and Insights
. 🚀 Join Premium Today & Enjoy ➤ 🎓 Full GPCR University + 🔬 200+ expert talks 🗞️ Weekly research,
- GPCR Drug Discovery at Discovery on Target: Why This Track Is About More Than Receptors
Here’s who we've talked to so far: 🎥 Check out the interview with Dr.
- Fluorescence Polarization in GPCR Research
Using this method, binding affinity, kinetics and selectivity can all be measured and used to establish equipment for analysis and plate readers are usually available in regular laboratories, although not all Table 1.
- Is Your GPCR Drug Discovery Program Built for Breakthroughs or Breakdowns?
Part 5: Your Precision Blueprint : I'll tie it all together, providing a concise, actionable guide for scientific and operational guidance to accelerate discovery . 🚀 Book your free 30-minute strategy call
- GPCR Allostery: Unlock Hidden Mechanisms and Make Smarter Drug Decisions
Sharpen your discovery decisions ➤ GPCR Signal Transduction Call for Papers: Define What Comes Next Volume signals today will shape tomorrow’s breakthroughs—and avoid delays others won’t see coming. 👉 Access all
- 📰 GPCR Weekly News - January 2 to 8, 2023
Sherwin Sells 30,000 Shares STALICLA signs agreement with Novartis on neurodevelopmental disorders Call
- 📰 GPCR Weekly News, April 17 to 23, 2023
Submit your interest in giving a talk or presenting a poster to Hello@DrGPCR.com. Don't miss out!
- 📰 GPCR Weekly News
Special report 2022: Meet 20 women blazing trails in biopharma R&D ERNEST - 2022 Scientific Outputs Call
- 📰 GPCR Weekly News, October 23 to 29, 2023
We're proud sponsors and can't wait to connect with all of you. See you there! Find speaker details on the Live Talks page and mark your calendar HERE.
- Chemical Drug Matter : Rethinking the Molecules We Choose to Develop In Drug Discovery
Pipeline Efficiency Begins With the Chemistry Itself Drug discovery pipelines often stall not because
- Your GPCR Program Decisions Depend on Good Data Interpretation
publications : AlphaFold3 benchmarking for GPCRs; new structural insights into peptide ligand activation All Don’t Fall Behind—Access the Edge You Need 👉 Access all the news and upcoming events ➤ Already a Premium
- What's Going On with GPCRs?! Find Out in This Week's Update! ⦿ Nov 4 - 10, 2024
Join us for this week’s update, where you’ll find all the latest breakthroughs and exciting developments Liangliang Zhou , Chungong Yu , Haicang Zhang , Dongbo Bu 🤩 Seriously, why would you want to miss out on all As a premium member , you have access to all the complimentary perks as well as: Dr. GPCR University 🎥 Access to the recorded classes of GPCR Courses and talks from Symposia 💲 Discounted
- Class B1 GPCR Dimerization: Unveiling Its Role in Receptor Function and Signaling
stable, are believed to influence the function and regulation of GPCRs—a process known as receptor cross-talk
- 📰 GPCR Weekly News, May 22 to 28, 2023
You can now watch the live talk recordings from the previous symposiums, check them out here.
- How Collaboration Drives GPCR Discoveries
No one person can be excellent at all of it — and pretending otherwise slows discovery. about trust — the kind of trust built when collaborators confirm your data, replicate your results, and call
- 📰 GPCR Weekly News, January 23 to 29, 2023
development of cachexia therapeutics Sosei Heptares Webinar Presentation for FY2022 Financial Results Call
- 📰 GPCR Weekly News, May 1 to 7, 2023
Industry News Addex Therapeutics to Release Q1 2023 Financial Results and Host Conference Call on May Beat Expectations, EPS Lags “As Precision Medicine is critical, we cannot think about one size fits all
- 📰 GPCR Weekly News, January 16 to 22, 2023
Christopher Prior, as CEO and Reports Recent Drug Discovery Highlights Call for GPCR Papers GPCRs: Signal
- 📰 GPCR Weekly News - January 9 to 15, 2023
collaborations GPCR Therapeutics Announces Launch of US Phase 2 Trial of GPC-100 in Multiple Myeloma Call
- 📰 GPCR Weekly News, July 17 to July 23, 2023
Premium members can always go back and watch the recorded talks at any time. Submit a 1-minute abstract video and tell us more about your project in this form.
- 📰 GPCR Weekly News, October 16 to 22, 2023
You can find more information about them on the Live Talks page and mark your calendar HERE.
- Orthosteric vs. Allosteric Interactions: The Silent Decider of Safety and Success
orthosteric and allosteric interactions as interchangeable, you’re leaving precision (and money) on the table
- Optimizing HTRF Assays with Fluorescent Ligands: Time-Resolved Fluorescence in GPCR Research
The donors act as light-harvesting antennas, capturing light from all directions, unlike the dipole-dipole This has been done in assays tracking IP1 and cAMP to detect biased agonism in GPCR ligands Table 1.
- Why Opposing Processes Matter for Your Next GPCR Drug
Drug pipelines live and die by your ability to make fast, accurate calls. A renin inhibitor that lowers blood pressure in healthy volunteers might not drop blood pressure at all Reflexes as Drug Design Partners Not all reflexes are enemies. Some can make a mediocre drug shine. Ligands come and go, feedback loops kick in, and what you see in vitro rarely tells the whole story.
- 📰 GPCR Buzz: August 5-11, 2024 | Top Highlights from DrGPCR University!
GPCR University offers two live courses this fall that you won’t want to miss.
- Exploring the Breakthroughs in GPCR Research
interactions of the serotonin1A receptor Industry News Neurocrine Biosciences Announces Conference Call
- 📰 GPCR Weekly News, June 24 to 30, 2024
GPCR Ecosystem this fall.
- 📰 GPCR Weekly News, February 13 to 19, 2023
Artificial Intelligence for Drug Discovery Call for GPCR Papers GPCRs: Signal Transduction.
- 📰 GPCR Weekly News, December 4 to 10, 2023
Nouvelle-Aquitaine Region Governor GPCR Events, Meetings, and Webinars January 16 - 19, 2024 | 23rd Annual PEP Talk
- 📰 GPCR Weekly News, February 6 to 12, 2023
Listing Rule 5635(c)(4) arcoscreen is one of the 13 biotech companies to discover in western in 2023 Call















